 |
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Supplement Article |
*Department of Nephrology, Monash Medical Centre; Department of Epidemiology and Preventive Medicine, Monash University; and International Diabetes Institute, Melbourne, Australia.
Correspondence to Professor Robert Atkins, Department of Nephrology, Monash Medical Centre, 265 Clayton Road, Clayton, Victoria, Australia. Phone: 61-3-9594-3518; Fax: 61-3-9594-6530;
ABSTRACT. The incidence of ESRD is increasing dramatically. Progression to end-stage may be halted or slowed when kidney damage is detected at an early stage. Kidney damage is frequently asymptomatic but is indicated by the presence of proteinuria, hematuria, or reduced GFR. Population-based studies relating to the prevalence of kidney damage in the community are limited, particularly outside of the United States. Therefore, the prevalence of proteinuria, hematuria, and reduced GFR in the Australian adult population was determined using a cross-sectional study of 11,247 noninstitutionalized Australians aged 25 yr or over, randomly selected using a stratified, cluster method. Subjects were interviewed and tested for proteinuria—spot urine protein to creatinine ratio (abnormal: 
0.20 mg/mg); hematuria—spot urine dipstick (abnormal: 1+ or greater) confirmed by urine microscopy (abnormal: >10,000 red blood cells per milliliter) or dipstick (abnormal: 1+ or greater) on midstream urine sample; and reduced GFR—Cockcroft-Gault estimated GFR (abnormal: <60 ml/min per 1.73 m2). The associations between age, gender, diabetes mellitus, and hypertension, and indicators of kidney damage were examined. Proteinuria was detected in 2.4% of cases (95% CI: 1.6%, 3.1%), hematuria in 4.6% (95% CI: 3.8%, 5.4%), and reduced GFR in 11.2% (95% CI: 8.6%, 13.8%). Approximately 16% had at least one indicator of kidney damage. Age, diabetes mellitus, and hypertension were independently associated with proteinuria; age, gender, and hypertension with hematuria; and age, gender, and hypertension with reduced GFR. Approximately 16% of the Australian adult population has either proteinuria, hematuria, and/or reduced GFR, indicating the presence of kidney damage. Identifying and targeting this section of the population may provide a means to reduce the burden of ESRD. E-mail: bob.atkins@med.monash. edu.au
This article has been cited by other articles:
 |
|
 |
|
  E. Noble, D. W. Johnson, N. Gray, P. Hollett, C. M. Hawley, S. B. Campbell, D. W. Mudge, and N. M. Isbel The impact of automated eGFR reporting and education on nephrology service referrals Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3845 - 3850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chen, W. Chen, H. Wang, X. Dong, Q. Liu, H. Mao, J. Tan, J. Lin, F. Zhou, N. Luo, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China Nephrol. Dial. Transplant., October 24, 2008; (2008) gfn604v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Huttner, E. U. Graefe-Mody, B. Withopf, A. Ring, and K. A. Dugi Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase 4, in Healthy Male Volunteers J. Clin. Pharmacol., October 1, 2008; 48(10): 1171 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Sumaili, J.-M. Krzesinski, C. V. Zinga, E. P. Cohen, P. Delanaye, S. M. Munyanga, and N. M. Nseka Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo Nephrol. Dial. Transplant., August 20, 2008; (2008) gfn469v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. White, K. McGeechan, M. Jones, A. Cass, S. J. Chadban, K. R. Polkinghorne, V. Perkovic, and P. J. Roderick Socioeconomic Disadvantage and Kidney Disease in the United States, Australia, and Thailand Am J Public Health, July 1, 2008; 98(7): 1306 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Carter, S. E. O'Riordan, G. L. Eaglestone, M. P. Delaney, and E. J. Lamb Chronic kidney disease prevalence in a UK residential care home population Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1257 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Roderick, R. J. Atkins, L. Smeeth, D. M. Nitsch, R. B. Hubbard, A. E. Flectcher, and C. J. Bulpitt Detecting chronic kidney disease in older people; what are the implications? Age Ageing, March 1, 2008; 37(2): 179 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Richards, K. Harris, M. Whitfield, D. O'Donoghue, R. Lewis, M. Mansell, S. Thomas, J. Townend, M. Eames, and D. Marcelli The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting Nephrol. Dial. Transplant., February 1, 2008; 23(2): 556 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Orth and S. I. Hallan Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence? Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 226 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. T. Raymond, D. Zehnder, S. C. H. Smith, J. A. Stinson, H. Lehnert, and R. M. Higgins Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3214 - 3220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ferris, S. L. Hogan, H. Chin, D. A. Shoham, D. S. Gipson, K. Gibson, S. Yilmaz, R. J. Falk, and J. C. Jennette Obesity, Albuminuria, and Urinalysis Findings in US Young Adults from the Add Health Wave III Study Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1207 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ludlow, G. Luxton, and T. Mathew Effects of fluoridation of community water supplies for people with chronic kidney disease Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2763 - 2767. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Perkovic, T. Ninomiya, H. Arima, M. Gallagher, M. Jardine, A. Cass, B. Neal, S. MacMahon, and J. Chalmers Chronic Kidney Disease, Cardiovascular Events, and the Effects of Perindopril-Based Blood Pressure Lowering: Data from the PROGRESS Study J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2766 - 2772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Klebe, J. Irving, P. E. Stevens, D. J. O'Donoghue, S. de Lusignan, R. Cooley, H. Hobbs, E. J. Lamb, I. John, R. Middleton, et al. The cost of implementing UK guidelines for the management of chronic kidney disease Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2504 - 2512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. MacGregor How common is early chronic kidney disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix8 - ix18. [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, L. Zuo, G. Xu, F. Wang, M. Wang, S. Wang, J. Lv, L. Liu, and H. Wang Community-based screening for chronic kidney disease among populations older than 40 years in Beijing Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1093 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Viktorsdottir, R. Palsson, M. B. Andresdottir, T. Aspelund, V. Gudnason, and O. S. Indridason Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1799 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
